secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2024-10-25T23:59:59+00:00
Accession:  0001722482-24-000161
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor Q3 net sales $1.71B (-0.3%), net income $57.8M, raises FCF guidance
---------------------------------------------------------------------------

- Net sales $1,714.4M, down 0.3% reported; organic decline 0.7%; currency tailwind of 0.4%.
- GAAP diluted EPS $0.08; adjusted EPS $0.26; adjusted EBITDA $302.5M (17.6% margin).
- Lab Solutions sales +1.1% reported (+0.6% organic); Bioscience Production -3.2% (-3.5% organic).
- Operating cash flow $244.8M; free cash flow $204.0M; management raised full-year FCF guidance.
- Adjusted net leverage 3.8x; bioprocessing outperformance and cost programs ahead of plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000172248224000161/0001722482-24-000161-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000172248224000161/avtr-20241025.htm
  HTML page:      https://secwatch.observer/filing/0001722482-24-000161

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer